Neurostimulation is a process that is used as a diagnosis and treatment of the nervous system. With the help of this therapy chronic pain related to neurological conditions such as epilepsy, Parkinson’s disease, neuropathic pain, nociceptive pain, and depression can be reduced. Neurostimulation therapy helps to improve life quality of patients suffering from obesity, paralysis, and severe sensory organs loss. A neurostimulation device is an important part of neural prosthetics for artificial limbs, vision and hearing aids. They comprise non-implantable and implantable devices that deliver electrical, chemical or other agents that modify brain cells and nerve cell activity. These devices can be inserted into the organs through surgical procedure, and can be operated by thin leads and wires.
Request Free Sample Copy With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/430
Rise in the number of Parkinson’s disease cases is expected to propel growth of the global neurostimulation devices market during the forecast period. For instance, the Parkinson’s Foundation estimated that Parkinson’s affects nearly 60,000 people every year, and it will affect nearly 1 million people by 2020 in U.S., and by 2030, it expected to affect nearly 1.2 million people in the U.S.
Furthermore, in 2018, the Global Burden of Disease study reported that neurological diseases caused most of the disabilities across the world, and Parkinson’s is the fastest growing disease among them. According to the same study, the Parkinson’s disease cases increased all over the world to 6.2 million, which is 118% from 1990 to 2015.
Increasing product recalls are expected to hinder growth of the global neurostimulation devices market during the forecast period. For instance, in November 2014, the U.S. FDA announced the recall of external neurostimulator of Medotronics as its cycling feature allowed stimulation output to be switched on and off depending on the programmed settings and the device failed to provide precise information.
Among regions, Europe is expected to witness strong growth in the global neurostimulation devices market during the forecast period after North America. For instance, in January 2017, Abbott announced the launch of Proclaim DRG neurostimulation System in Europe. The product is intended to deliver dorsal root ganglion (DRG) stimulation to patients with chronic neuropathic pain.
Request PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/430
Moreover, Asia Pacific is expected to witness robust growth in the neurostimulation devices market during the forecast period. For instance, in 2015, the Alzheimer’s disease International reported that dementia affected 23 million people in the Asia Pacific, and the number is likely to increase by 2050 to 71 million.
Major players functioning in the global neurostimulation devices market are Neurosigma, St. Jude Medical Inc. (Abbott), electroCore LLC, Endostim Inc., Virtual Medical Centre Inc., Boston Scientific Corporation, NDI Medical, Electro Medics, and NeuroPace, Inc.
By device type:
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Gastric Electric Stimulators
- Spinal Cord Stimulators
- Vagus Nerve Stimulators
- Parkinson’s Disease
- Essential Tremor
- Urinary and Fecal Incontinence
By end user:
- Medical Clinics
- Rehabilitation Centers
- North America
- Latin America
- Middle East
- Asia Pacific
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/430
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Neurostimulation Devices Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Neurostimulation Devices Industry Impact
Chapter 2 Neurostimulation Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Neurostimulation Devices (Volume and Value) by Type
2.3 Neurostimulation Devices (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Neurostimulation Devices Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Neurostimulation Devices Market Analysis
Chapter 6 East Asia Neurostimulation Devices Market Analysis
Chapter 7 Europe Neurostimulation Devices Market Analysis
Chapter 8 South Asia Neurostimulation Devices Market Analysis
Chapter 9 Southeast Asia Neurostimulation Devices Market Analysis
Chapter 10 Middle East Neurostimulation Devices Market Analysis
Chapter 11 Africa Neurostimulation Devices Market Analysis
Chapter 12 Oceania Neurostimulation Devices Market Analysis
Chapter 13 South America Neurostimulation Devices Market Analysis
Chapter 14 Company Profiles and Key Figures in Neurostimulation Devices Business
Chapter 15 Neurostimulation Devices Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027